Clinical Trial Update: Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial studying the safety and pharmacokinetics of montelukast in Japanese children with perennial allergic rhinitis has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2014-09-29